HIGHLIGHTS
- who: Metronomic Chemotherapy and colleagues from the Medical Oncology, "DCamberlingo" Hospital, Italy have published the paper: Exceptional Long Term Complete Response to Metronomic Chemotherapy in Advanced Breast Cancer, in the Journal: (JOURNAL) of April/09,/2022
- what: In MBC several studies have provided data on the clinical efficacy and low toxicity profile of metronomic chemotherapy Herein the authors report the case of a 68-year-old woman with breast cancer and associated synchronous lymph nodes and lung metastases who experienced exceptional long term complete response with low dose metronomic chemotherapy.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.